RocketTickers

Theravance Biopharma, Inc. Announces Top-line Results from a Pha

Long
NASDAQ:TBPH   Theravance Biopharma, Inc.
TBPH: Theravance Biopharma, Inc.
2021-09-15 06:05:00
Theravance Biopharma, Inc. Announces Top-line Results from a Phase 3 Study of Ampreloxetine in Patients with Symptomatic Neurogenic Orthostatic Hypotension
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.